Inspire Medical Systems
INSPInspire Medical Systems is a medical technology company that develops and commercializes minimally invasive neurostimulation solutions for patients with obstructive sleep apnea (OSA).
Earnings
Next report
Aug 3, 2026 (In 5 days)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Inspire Medical Systems is a medical technology company that develops and commercializes minimally invasive neurostimulation solutions for patients with obstructive sleep apnea (OSA). Its proprietary technology provides a closed-loop system that monitors breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway, serving as a primary alternative for patients who cannot tolerate Continuous Positive Airway Pressure (CPAP) therapy.
The company is a first-mover in the hypoglossal nerve stimulation market with the first FDA-approved closed-loop neurostimulation technology for OSA.
Questions, answered.
- What is Inspire Medical Systems's market cap?
- Inspire Medical Systems (INSP) has a market capitalization of $1.5B and trades on NYSE.
- What is Inspire Medical Systems's revenue and profitability?
- Inspire Medical Systems generated $915.2M in trailing twelve-month revenue with net income of $131.1M, representing a net margin of 14.3%. Gross margin stands at 85.8%, with free cash flow of $96.7M. These figures are based on the Q1 2026 filing.
- Who are Inspire Medical Systems's competitors?
- Inspire Medical Systems's key competitors include LivaNova, ResMed, Philips, and others. These companies compete in similar markets and product categories.
- Where is Inspire Medical Systems headquartered?
- Inspire Medical Systems is headquartered in United States of America and employs approximately 1,011 people. It has been publicly traded since 2018.
